AI in Pharma
Article
The Top AI Chemistry Platforms Transforming Small Molecule Oncology in 2026
Fewer than 700 of 20,000 human proteins have ever yielded a drug. 5 AI platforms are unlocking oncology's "undruggable" targets.
Other latest pieces about AI in Pharma you may like to read
The Top AI Chemistry Platforms Transforming Small Molecule Oncology in 2026
Fewer than 700 of 20,000 human proteins have ever yielded a drug. 5 AI platforms are unlocking oncology's "undruggable" targets.
by Mrudula Kulkarni
Quantifying the ROI: Do AI Chemistry Platforms Actually Reduce Pharma R&D Costs?
AI drug discovery raised billions in deals. Deloitte's 2026 report found the ROI "hasn't been realized at scale" yet. Here's why.
by Mrudula Kulkarni
8 Things to Know About Rasayan Labs, the Startup Building an AI Operating System for Drug Discovery
Discover how Rasayan Labs accelerates drug discovery with an AI platform for retrosynthesis, ADMET, patents, and compound research.
by Team Pharma Now
The Patent Problem: Who Really Owns What AI Discovers in Science?
AI is discovering drugs but cannot own a patent. Explore who holds IP rights in AI-assisted pharma discovery and what your team must do.
by Vaibhavi M.
When AI Gets It Wrong: The Real Patient Safety Risk of AI Hallucinations in Healthcare
AI hallucinations in pharma are a real patient safety risk. Wrong doses, false data, missed signals here's what governance looks like.
by Vaibhavi M.
